We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

38 hedge funds and large institutions have $64.4M invested in Apollo Endosurgery, Inc. in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

8% more capital invested

Capital invested by funds: $59.7M → $64.4M (+$4.67M)

3% more funds holding

Funds holding: 3738 (+1)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
38
Holders Change
+1
Holders Change %
+2.7%
% of All Funds
0.87%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
6
Increased
11
Reduced
9
Closed
5
Calls
Puts
Net Calls
Net Calls Change

APEN Hedge Fund Activity: Q3 2018 in Review

38 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q3 2018, worth a combined $64.4M — up 7.8% from $59.7M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new APEN positions and 5 closed out — a net gain of 1 holder — while 11 added to existing stakes and 9 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $4.21M. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $2.79M sold.

  • 38 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q3 2018, up from 37 in Q2 2018.
  • Funds reported $64.4M of Apollo Endosurgery, Inc. stock for Q3 2018, up 7.8% quarter-over-quarter.
  • 6 funds opened new Apollo Endosurgery, Inc. positions in Q3 2018 and 5 closed out, a net change of +1 holder.
  • The largest Apollo Endosurgery, Inc. buyer in Q3 2018 was Nantahala Capital Management, an estimated $4.21M added.
  • The largest Apollo Endosurgery, Inc. seller in Q3 2018 was Polar Asset Management Partners, an estimated $2.79M sold.

Based on aggregated 13F filings for Q3 2018.